L. Ruiz Gutiérrez, A. Abbasi Pérez, P. Pretel Ruiz, J. Campos Esteban, A. Movasat Hajkhan
{"title":"Artritis psoriásica","authors":"L. Ruiz Gutiérrez, A. Abbasi Pérez, P. Pretel Ruiz, J. Campos Esteban, A. Movasat Hajkhan","doi":"10.1016/j.med.2025.05.002","DOIUrl":null,"url":null,"abstract":"<div><div>Psoriatic arthritis (PsA) is a chronic inflammatory disease that can affect joints, tendons, entheses, and the axial skeleton. It usually occurs in patients with psoriasis. It is a complex, multifactorial disease favored by genetic, environmental, and immunological factors, among which TNF-alpha, IL-23, and IL-17 are the most important. There are no validated diagnostic criteria for PsA, but the CASPAR <em>(ClASsification criteria for Psoriatic Arthritis</em>) criteria can serve as a guide in clinical practice. In addition to joint manifestations, patients may present with extramusculoskeletal manifestations and comorbidities that must be taken into account in the management of the disease. Conventional, biological, or synthetic disease-modifying antirheumatic drugs (DMARDs) are available for its treatment.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 32","pages":"Pages 1923-1931"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225001179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Psoriatic arthritis (PsA) is a chronic inflammatory disease that can affect joints, tendons, entheses, and the axial skeleton. It usually occurs in patients with psoriasis. It is a complex, multifactorial disease favored by genetic, environmental, and immunological factors, among which TNF-alpha, IL-23, and IL-17 are the most important. There are no validated diagnostic criteria for PsA, but the CASPAR (ClASsification criteria for Psoriatic Arthritis) criteria can serve as a guide in clinical practice. In addition to joint manifestations, patients may present with extramusculoskeletal manifestations and comorbidities that must be taken into account in the management of the disease. Conventional, biological, or synthetic disease-modifying antirheumatic drugs (DMARDs) are available for its treatment.